Xlife Sciences Stock price
CHF9.80
-4.90
33.33%
1M
-11.70
54.42%
6M
-14.90
60.32%
YTD
-10.90
52.66%
1Y
-30.20
75.50%
3Y
-42.20
81.15%
5Y
-42.20
81.15%
10Y
-42.20
81.15%
20Y
SIX Swiss Exchange,
Closing price Fri, Oct 09 2026
-0.10
1.01%
Powered by
ISIN
CH0461929603
Symbol
XLS
Industry
Is Xlife Sciences a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.
Key metrics
Basic
Market capitalization
CHF56.2m
Enterprise Value
CHF115.8m
Net debt
CHF59.5m
Cash
CHF1.1m
Shares outstanding
5.8m
Valuation
P/E
-
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
negative | -
P/B
0.2
Financial Health
Equity Ratio
55.4%
Return on Equity
-7.5%
ROCE
-
ROIC
-
Debt/Equity
0.2
Xlife Sciences Stock Analysis
Unlock Scores for Free
Analyst Opinions
5 Analysts have issued a Xlife Sciences forecast:
Analyst Opinions
5 Analysts have issued a Xlife Sciences forecast:
Buy
80%
Hold
20%
Don't miss a Thing! We will send you all news about Xlife Sciences directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Switzerland.
| Head office | Switzerland |
| CEO | Oliver Baumann |
| Employees | 20 |
| Website | www.xlifesciences.ch |


